US Patent Issued to Bayer, The Broad Institute, Dana-Farber Cancer Institute on July 28 for "Substituted heterocyclic compounds and therapeutic uses thereof" (German, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,261, issued on July 28, was assigned to Bayer AG (Leverkusen, Germany), The Broad Institute Inc. (Cambridge, Mass.) and Dana-Farber Cancer Institute Inc. (Boston).

"Substituted heterocyclic compounds and therapeutic uses thereof" was invented by Volker Schulze (Hohen Neuendorf, Germany), Anne Mengel (Berlin), Clara Adelaide Faria Alvares De Lemos (Berlin), Sven Christian (East Boston, Mass.), Ulf Bomer (Glienicke, Germany), Roman Hillig (Berlin), Christian Lechner (Berlin), Jeremie Xavier Mortier (Berlin), Stefan Kaulfuss (Berlin), Steven Corsello (Boston), Katarzyna Handing (Framingham, Mass.), Amael Madec (Boston), Laura Furst (Somerville, Mass.), Mrinal Shekhar (Quincy, Mass.),...